Abstract: Rheumatic immune disease and tuberculosis (TB) are both chronic diseases that require long-term treatment and continuous management. Because patients with rheumatic immune disease have abnormal autoimmune functions and may receive treatment with drugs such as corticosteroids and anti-tumor necrosis factor inhibitors, they are more likely to be infected with Mycobacterium tuberculosis and even suffer from active TB compared with general population. This study comprehensively analyzes the prevalence of rheumatic immune disease complicated with TB, influencing factors, prevention and control strategies, screening programs and challenges in the prevention and control, and suggests improvement focus to strengthen the prevention and control of rheumatic immune disease complicated with TB, including disease burden survey and research at national level, collaboration among departments, screening for TB in rheumatic immune disease patients, accessibility of health service resources, and the medical cost burden of patients, to provide reference for the development of more effective strategies and policies to prevent and control rheumatic immune disease complicated with TB.